Literature DB >> 6721794

A comparison of avian and mammalian cell cultures for the propagation of avian reovirus WVU 2937.

V Barta, W T Springer, D L Millar.   

Abstract

Two avian and seven mammalian cell lines were evaluated for their application in propagating avian reovirus WVU 2937. Cultures were compared for monolayer-formation time, support of viral replication, passages and postinfection time required for expression of cytopathic effect (CPE), type of CPE, and virus yield. CPE was observed on the first passage with infected egg yolk in primary chicken embryo kidney cells, primary through tertiary chicken embryo liver (CEL) cells, and African green monkey kidney (VERO) cells; on the third blind passage of infected supernatant in Georgia bovine kidney cells, Crandall feline kidney cells, and baby hamster cells; on the fifth blind passage in rabbit kidney cells; and on the tenth blind passage in porcine kidney cells. CPE was not observed after 10 viral passages in rabbit bone-marrow cells. Monolayer formation time and postinfection time for CPE expression occurred sooner, and virus yield was greater, with CEL and VERO cells than with other cell lines.

Entities:  

Mesh:

Year:  1984        PMID: 6721794

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  4 in total

1.  Avian reovirus S1133 can replicate in mouse L cells: effect of pH and cell attachment status on viral infection.

Authors:  M Mallo; J Martínez-Costas; J Benavente
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Preparation and evaluation of goose reovirus inactivated vaccine.

Authors:  Xiaoyu Niu; Bingqian Zhang; Xianglong Yu; Xin Zhang; Yanguo Dou; Yi Tang; Youxiang Diao
Journal:  BMC Vet Res       Date:  2017-07-06       Impact factor: 2.741

3.  A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines.

Authors:  Jens-Peter Gregersen
Journal:  Vaccine       Date:  2008-04-15       Impact factor: 3.641

4.  A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine.

Authors:  Jens-Peter Gregersen
Journal:  Vaccine       Date:  2008-04-18       Impact factor: 3.641

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.